Figure 7.
HLAcII-DRB1 coverage in this study and comparison of FVIII peptides identified in this study and those identified in previous studies. (A) The bar labeled “World” represents a set of 38 MHC-II–DRB1 alleles and their respective frequencies in the world population; together, these alleles represent 95.42% of alleles found in this population. The bar labeled “Study” represents the 16 alleles found in the subjects of the MAPPS assays. This subset represents 59.89% of alleles found in the world population. The relative frequencies of the MHC-II–DRB1 alleles in the study population and the world population are comparable. (B) Previous studies have identified FVIII peptides in MAPPs assays using a BDD-rFVIII, whose primary amino acid sequence corresponds exactly to that of the BDD-rFVIII used in this study; the peptides identified in studies by Peyron et al26 (green), van Haren et al25 (blue), and in the current study are shown for comparison.

HLAcII-DRB1 coverage in this study and comparison of FVIII peptides identified in this study and those identified in previous studies. (A) The bar labeled “World” represents a set of 38 MHC-II–DRB1 alleles and their respective frequencies in the world population; together, these alleles represent 95.42% of alleles found in this population. The bar labeled “Study” represents the 16 alleles found in the subjects of the MAPPS assays. This subset represents 59.89% of alleles found in the world population. The relative frequencies of the MHC-II–DRB1 alleles in the study population and the world population are comparable. (B) Previous studies have identified FVIII peptides in MAPPs assays using a BDD-rFVIII, whose primary amino acid sequence corresponds exactly to that of the BDD-rFVIII used in this study; the peptides identified in studies by Peyron et al26  (green), van Haren et al25  (blue), and in the current study are shown for comparison.

Close Modal

or Create an Account

Close Modal
Close Modal